Trailing-twelve-month (TTM) revenue is $44.07 Billion with a year-over-year growth of +1.88%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-28 | $11,271,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q1 FY2026Period ended 2025-12-28 | $12,252,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q2 FY2026Period ended 2026-03-29 | $10,599,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q3 FY2026Period ended 2026-06-28 | $9,947,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $44,069,000,000 |
Current P/S: $185,724,000,000 market capitalization ÷ $44,069,000,000 TTM revenue = 4.21x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T20:00:00.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-28): $9.95B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2023-09-24 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-27 · USD | FY20212021-09-26 · USD | FY20222022-09-25 · USD | FY20232023-09-24 · USD | FY20242024-09-29 · USD | FY20252025-09-28 · USD |
|---|---|---|---|---|---|---|
| Other Segments | $133M | $128M | $134M | $144M | N/A | N/A |
| QCT | $16.5B | $27.0B | $37.7B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-09-30 · USD | FY20192019-09-29 · USD | FY20202020-09-27 · USD | FY20212021-09-26 · USD | FY20222022-09-25 · USD | FY20232023-09-24 · USD |
|---|---|---|---|---|---|---|
| CHINA | $15.1B | $11.6B | $14.0B | $22.5B | $28.1B | $22.4B |
| IRELAND | N/A | $3.0B | $867M | $1.2B |
$44.07B
$44.07 Billion
+1.88%
vs. $43.26B a year ago (TTM)
+6.23%
5 Year compound annual growth rate
1 Year
+1.88%
3 Year
+4.52%
5 Year
+6.23%
10 Year
+6.80%
15 Year
+8.05%
20 Year
+9.56%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $44.28B | +$5.32B | +13.66% |
| 2024 | $38.96B | +$3.14B | +8.77% |
| 2023 | $35.82B | ($8.38B) | (18.96%) |
| 2022 | $44.20B | +$10.63B | +31.68% |
| 2021 | $33.57B | +$10.04B | +42.65% |
| 2020 |
TTM Growth
+1.88%
3-Year CAGR
+4.52%
5-Year CAGR
+6.23%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-10T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $33.2B |
| $38.4B |
| QSI | $36M | $45M | $31M | $28M | $18M | N/A |
|---|
| QTL | $5.0B | $6.3B | $6.4B | $5.3B | $5.6B | $5.6B |
|---|
| N/A |
| N/A |
| KOREA, REPUBLIC OF | $3.2B | $2.4B | $3.0B | $2.4B | $3.2B | $3.3B |
|---|
| Other Foreign | $3.8B | $4.5B | $4.6B | $6.1B | $5.4B | $4.4B |
|---|
| UNITED STATES | $603M | $2.8B | $1.1B | $1.4B | $1.5B | $1.3B |
|---|
| VIET NAM | N/A | N/A | N/A | N/A | $6.1B | $4.6B |
|---|
| $23.53B |
| ($742.00M) |
| (3.06%) |
| 2019 | $24.27B | +$1.54B | +6.78% |
| 2018 | $22.73B | +$441.00M | +1.98% |
| 2017 | $22.29B | ($1.26B) | (5.36%) |
| 2016 | $23.55B | ($1.73B) | (6.83%) |
